Between 7 February and 13 February, 346 Medtech companies posted 12,814 jobs worldwide, according to the GlobalData jobs analytics tool. This represents a decrease of around 9% from last week, which saw 351 companies post 14,050 jobs.

Bausch & Lomb remained by far the most prolific hirer, with 1,185 jobs posted across the course of the week. It was yet again followed by Biotronik, with 709 jobs, and Sonova Holding, with 664 jobs.

Bausch was on several major city hiring sprees across the US. This included 99 listings in Rochester, 89 in Lynchburg, 65 in St Louis, 59 in Bridgewater and 49 in Greenville. The firm also had 65 vacancies posted in Berlin.

Of the overall jobs posted this week, junior and entry-level positions made up 5,110 and 3,646 postings respectively, while 3,606 mid-level jobs were advertised. Senior positions saw a slight increase on the week before, with 452 positions advertised compared to last week’s 371.

PPD Group commended for employee development programs

PPD Group posted the most senior roles of any company, advertising 64 positions across the US and Europe. The contract research organisation provides lifecycle management services to medical device, pharmaceutical and biotechnology companies as well as academic and governmental organisations.

PPD has been recognised for the tenth year running as one of the leading US businesses for employee learning and development, having been named in Training magazine’s Top 100 list.

The list honours companies which demonstrate measurable results from effective employee learning and development tied to strategic goals.

“Earning this recognition for the 10th year in a row underscores PPD’s commitment to achieving effective training and employee development outcomes that provide tangible benefit to our customers and their drug-development initiatives,” said PPD senior vice president of quality and enterprise learning Jay Dixon. “Our learning culture contributes to making PPD a great company to work for and helps increase employee engagement and retention, enhancing continuity in our customers’ important research programs.”